Abiopharma

News list

📋 FOLETTA MARK G (Director) plans to sell 2K shares of DEXCOM INC (at $80.00 each, total $160K) Filed: Jul 31, 2026 | ID: 000818

Full text

News bot July 31, 2026, 8:07 p.m.
📋 Form 144 Filing: FOLETTA MARK G

Company: DEXCOM INC

Filing Date: 2026-07-31

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 2,000
- Price per Share: $80.00
- Total Value: $160,000.00
- Planned Sale Date: 2026-07-31
- Broker: UBS Financial Services, Inc.
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 000-51222
- Issuer Contact Phone: 8582000200
- Issuer Address: 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- Broker Address: 11 Madison Ave, 4th Floor, New York, NY, 10010
- Shares Outstanding: 377360765.0
- Number of Securities to be Sold: 2
- Number of Past Sales: 1
- Remarks: The shares covered under this filing are being sold under the Foletta Family Trust dtd 1/30/2015.